Giovanni Martinotti

Docente a contratto
Sede: Roma
Dipartimento: Scienze Umane (Comunicazione, Formazione, Psicologia)
Corso di laurea: Scienze e tecniche psicologiche

Insegnamenti e orario di ricevimento

  • Psichiatria

    Piazza delle Vaschette 101
    Giovedì ore 11.30-12.30. Si prega concordare l'appuntamento tramite e-mail
  • Curriculum Vitae

    Giovanni Martinotti, MD, PhD, MAA, PhB

    H-INDEX: 43    Total I.F.: 580

    Department of Neuroscience, Imaging, and Clinical Science, University “G.d’Annunzio”, Chieti-Pescara, Italy

    Department of Pharmacy, Pharmacology and Clinical Science, University of Hertfordshire, Herts, UK

     

    Current occupations:

    Academic activitiess

    Associate Professor: Department of Neuroscience, Imaging, and Clinical Science, University “G.d’Annunzio”, Chieti-Pescara, Italy

    Visiting Professor: Department of Pharmacy, Pharmacology and Clinical Science, University of Hertfordshire, Herts, UK

     

    Clinical activities

    Clinical activities, “SS. Annunziata” Hospital, ASL Chieti-Lanciano-Vasto, Psychiatric Ward (SPDC), Chieti, Italy

    Clinical and community activities, SRP “Villa Maria Pia", Rome, Italy

     

    Teaching appointments

    Lecturer in Psychiatry, University “G.d’Annunzio”, School of Medicine and Heath Sciences (Medicine and Surgey, Nursing Sciences, Occupational Therapy, Psychology, Post-graduate Residency School of Psychiatry), Chieti, Italy

    Lecturer in Clinical Psychiatry, Libera Università Maria S. Assunta (LUMSA), Depatment of Human Sciences, Schoole of Science and Psychological techniques, Rome, Italy

    Lecturer in Social Psychiatry, Catholic University of Rome, Post-graduate Residency in Psychiatry, Rome, Italy

    Lecturer and Didactic Coordinator, Postgraduate teaching; Master in Addictive Behaviours, Sacro Cuore Catholic University, Rome, Italy

    Lecturer in Psychopathology, Postgraduate teaching; Postgraduate Diploma School of Etno-Psychotherapy “Sagara”, Pisa, italy                       

    Lecturer in Psychopathology, Postgraduate teaching; Postgraduate Diploma School of Strategic Psychotherapies, Institute for the Study of Psychotherapy (ISP), Rome, Italy

    Lecturer in “Addiction and substance abuse”, Postgraduate teaching; Postgraduate Diploma School of Formation in Psychodinamic Psychotherapy, Scuola di Formazione di Psicoterapia ad Indirizzo Dinamico (SFPID), Rome, Italy

    Lecturer in Psychopathology, Postgraduate teaching; Postgraduate Diploma School of Academy of Psychoanalytic Psychotherapy (SAPP), Rome, Italy

    Lecturer in Psychiatry, Postgraduate teaching; Postgraduate Psychodiagnostic School “Humanitas”, Libera Università Maria S. Assunta (LUMSA), Rome, Italy

     

    Education – Schools and Universities attended, with dates

    PhD in “Methodology and advanced research in psychopathology and psychotherapy”; Sacro Cuore Catholic University, Rome, Italy (2005-2008)

    Postgraduate Residency Diploma in Psychiatry quoted as 50/50 “cum laude”. Title of the dissertation: “Phenomenology of the embodiment: clinic and psychopathology”; Sacro Cuore Catholic University, Rome, Italy (2001-2005)

    Degree in Medicine and Surgery quoted as 110/110 “cum laude”. Title of the dissertation: “Typologies of alcoholism and treatment efficacy in an Addiction Treatment Unit: a retrospective analysis”; Sacro Cuore Catholic University, Rome, Italy (1995-2001)

    Master in “Addictive Behaviour and related pathologies”; Sacro Cuore Catholic University, Rome, Italy (2007)

    Bachelor in Philosophy quoted as 110/110 “cum laude”; Sapienza University, Rome, Italy (2005-2008)                        

    Master of Arts Anthropology, quoted as 110/110 “cum laude”; Sapienza University, Rome, Italy (2009-2011)

    Scientific diploma quoted as 60/60; Collegio San Giuseppe, Istituto Villa Flaminia, Rome, Italy (1990-1995)

     

    Qualifications – Academic and professional – membership of bodies

    President of the young section of the Italian Society of Psychiatry, (since 2012)

    Secretary of the WPA Section of Ecology, Psychiatry, and Mental Health (since 2004)

    Secretary of the section of Suicidology, Italian Society of Psychiatry, (since 2012)

    Inclusion in the List of Psychotherapists, General Medical Council of Rome, Italy (since 2005)

    General Medical Council Full Registration, United Kingdom (UK; September 2002)

    Italian Medical Council registration (since 2001)

    Treasurer of the Italian Society of Psychiatry, regional section of Lazio (2010-2016)

     

    Personal skills: languages

    Mother tongue

    Italian

    Other languages

    UNDERSTANDING

    SPEAKING

    WRITING

    Listening

    Reading

    Spoken interaction

    Spoken production

     

    English

    Excellent

    Excellent

    Excellent

    Excellent

    Excellent

    Portuguese

    Excellent

    Excellent

    Excellent

    Excellent

    Good

    Spanish

    Excellent

    Excellent

    Excellent

    Excellent

    Good

    Arabic

    Basic

    Good

    Basic

    Basic

    Basic

    French

    Basic

    Basic

    Basic

    Basic

    Basic

     

     

     

     

     

     

     

     

     

     

     

     


    Principali pubblicazioni

    H-INDEX: 43 Total I.F.: 580

    Scientific Publications on Peer Review Journals with Impact Factor: 220

    1) D'Ascenzo M, Martinotti G, Azzena GB, Grassi C.cGMP/protein kinase G-dependent inhibition of N-type Ca2+ channels induced by nitric oxide in human neuroblastoma IMR32 cells. Journal of Neuroscience Sep 1;22(17):7485-92, 2002

    2) Schifano F, Leoni M, Martinotti G, Rawaf S, Rovetto F.Importance of cyberspace for the assessment of the drug abuse market: preliminary results from the Psychonaut 2002 project. Cyberpsychology and Behaviour Aug;6(4):405-10, 2003

    3) Schifano F, Oyefeso A, Corkery J, Cobain K, Jambert-Gray R, Martinotti G, Ghodse AH. Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996-2002. Human Psychopharmacology: Clinical and Experimental Oct;18(7):519-24, 2003

    4) Grassi C, D'Ascenzo M, Torsello A, Martinotti G, Wolf F, Cittadini A, Azzena GB.Effects of 50 Hz electromagnetic fields onvoltage-gated Ca2+ channels and their role in modulation of neuroendocrine cell proliferation and death. Cell Calcium Apr;35(4):307-15, 2004

    5) Janiri L, Martinotti G, Dario T, Reina D, Paparello F, Pozzi G, Addolorato G, Di Giannantonio M, De Risio S. Anhedonia and substance-related symptoms in detoxified drug dependent subjects: a correlation study. Neuropsychobiology 52(1): 37-44, 2005

    6) Grimaldi L, De Giorgio F, Masullo M, Zoccai GB, Martinotti G, Rainio J. Suicide by pencil. Journal of Forensic Science 50(4):913-4, 2005

    7) Schifano F, Deluca P, Agosti L, Martinotti G, Corkery JM, Alex B, Caterina B, Heikki B, Raffaella B, Anna C, Lucia DF, Dorte DR, Magi F, Susana F, Irene F, Claude G, Lisbet H, Lene SJ, Mauro L, Christopher L, Aino M, Teuvo P, Milena P, Salman R, Damien R, Angela RM, Francesco R, Norbert S, Holger S, Josep T, Marta T, Francesco Z; Psychonaut 2002 Research Group. New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 ('Blue Mystic'). Journal of Psychopharmacology 19(6):675-9, 2005

    8) Martinotti G, Andreoli S, Giametta M , Poli V , Bria P , Janiri L. The dimensional assessment of personality in pathological and social gamblers: the role of Novelty Seeking and Self-Transcendence. Comprhensive Psychiatry, 47(5):350-6, 2006

    9) Janiri L, Martinotti G, Dario T, Schifano F, Bria P. The gamblers’ temperament and character inventory (TCI) personality profile. Substance Use and Misuse 42(6):975-84, 2007

    10) Martinotti G, Romanelli R, Di Nicola M, Reina D, Janiri L. Oxcarbazepine at high dosages for the treatment of alcohol dependence. American Journal on Addictions, 16(3):247-8, 2007

    11) Martinotti G, Di Nicola M, Janiri L. Efficacy and safety of aripiprazole in alcohol dependence. American Journal on Drug and Alcohol Abuse, 33(3):393-401, 2007

    12) Martinotti G, Di Nicola M, Romanelli R, Andreoli S, Pozzi G, Moroni N, Janiri L. High and low dosage oxcarbazepine versus naltrexone for the prevention of relapse in alcohol-dependent patients. Human Psychopharmacology: Clinical and Experimental, 22(3):149-56, 2007

    13) Rusch N, Spoletini I, Wilke M, Bria P, Di Paola M, Di Iulio F, Martinotti G, Caltagirone C, Spalletta G.Prefrontal-thalamic-cerebellar gray matter networks and executive functioning in schizophrenia. Schizophrenia Research 93(1-3): 79-89, 2007

    14) Mazza M, Di Nicola M, Martinotti G, Taranto C, Pozzi G, Conte G, Janiri L, Bria P, Mazza S. Oxcarbazepine in bipolar disorder: a critical review of the literature. Expert Opinion on Pharmacotherapy 8(5):649-56, 2007

    15) Mazza M, Della Marca G, Di Nicola M, Martinotti G, Pozzi G, Janiri L, Bria P, Mazza S.Oxcarbazepine improves mood in patients with epilepsy. Epilepsy and Behaviour 10(3):397-401, 2007

    16) Janiri L, Martinotti G, Di Nicola M. Aripiprazole for relapse prevention and craving in alcohol-dependent subjects: results from a pilot study. Journal of Clinical Psychopharmacology 27(5):519-20, 2007

    17) Martinotti G, Di Nicola M, Reina D, Andreoli S, Focà F, Cunniff A, Tonioni F, Bria P Janiri L. Alcohol protracted withdrawal syndrome: the role of anhedonia. Substance Use and Misuse 43(3):271-84, 2008

    18) Pozzi G, Martinotti G, Reina D, Dario T, Frustaci A, Janiri L, Bria P. Post-detoxification anhedonia: influence of clinical and psychosocial characteristics. Substance Use and Misuse 43(5):722-32, 2008

    19) Martinotti G, Cloninger CR, Janiri L. Temperament and character inventory dimensions and anhedonia in detoxified substance-dependent subjects. American Journal on Drug and Alcohol Abuse, 34(2):177-83, 2008

    20) Martinotti G, Andreoli S, Di Nicola M, Di Giannantonio M, Sarchiapone M, Janiri L. Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics. Human Psychopharmacology: Clinical and Experimental 23: 1–8, 2008

    21) Martinotti G, Di Nicola M, Tedeschi D, Mazza M, Janiri L, Bria P. Efficacy and safety of pregabalin in alcohol dependence. Advances in Therapy 25(6):608-18, 2008

    22) Marini A, Spoletini I, Rubino IA, Ciuffa M, Bria P, Martinotti G, Banfi G, Boccascino R, Strom P, Siracusano A, Caltagirone C, Spalletta G.The language of schizophrenia: An analysis of micro and macrolinguistic abilities and their neuropsychological correlates. Schizophrenia Research, 2008 Oct;105(1-3):144-55.

    23) Martinotti G, Mandelli L, Di Nicola M, Serretti A, Fossati A, Borroni S, Cloninger CR, Janiri L. Psychometric characteristic of the Italian version of the Temperament and Character Inventory--revised, personality, psychopathology, and attachment styles. Comprehensive Psychiatry, 2008 Sep-Oct;49(5):514-22.

    24) Rusch N, Spoletini I, Wilke M, Martinotti G, Bria P, Trequattrini A, Bonaviri G, Caltagirone C, Spalletta G. Inferior frontal white matter volume and suicidality in schizophrenia. Psychiatry Research, 2008 Dec 30;164(3):206-14

    25) Mazza M, Mandelli L, Di Nicola M, Harnic D, Catalano V, Tedeschi D, Martinotti G, Colombo R, Bria P, Serretti A, Janiri L. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up. Journal Affective Disorders, 2009 May;115(1-2):27-35.

    26) Martinotti G, Di Nicola M, Di Giannantonio M, Janiri L. Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. Naltrexone. Journal Psychopharmacology, 2009 Mar;23(2):123-9.

    27) Janiri L, Martinotti G, Tonioni F, Ghelardini C, Galeotti N, Nicolai R, Mosconi L, Calvani M, Bartolini A. Acetyl-L-carnitine in the management of pain during methadone withdrawal syndrome. Neuropsychopharmacology, 2009 Jan-Feb;32(1):35-40.

    28) Spoletini I, Cherubini A, Di Paola M, Banfi G, Rüsch N, Martinotti G, Bria P, Rubino IA, Siracusano A, Caltagirone C, Spalletta G. Reduced fronto-temporal connectivity is associated with frontal gray matter density reduction and neuropsychological deficit in schizophrenia. Schizophrenia Research, 2009 Mar;108(1-3):57-68..

    29) Martinotti G, Di Nicola M, Tedeschi D, Cundari S, Janiri L. Empathy ability is impaired in alcohol-dependent patients. American journal on Addictions, 2009 Mar-Apr;18(2):157-61

    30) Martinotti G, Di Nicola M, Andreoli S, Mazza M, Pomponi M, Tedeschi D, Romanelli R, Moroni N, Pozzi G, Bria P, Janiri L. Pregabalin versus Naltrexone in alcohol dependence: a randomised, double-blind, comparison trial. Journal Psychopharmacology, 2010 Sep;24(9):1367-74

    31) Mandelli L, Mazza M, Martinotti G, Di Nicola M, Daniela T, Colombo E, Missaglia S, De Ronchi D, Colombo R, Janiri L, Serretti A. Journal Affective Disorders, 2009 Dec;119(1-3):205-9.

    32) Tonioni F, Martinotti G, Barra A, Martinelli D, Autullo G, Rinaldi C, Tedeschi D, Janiri L, Bria P. Cocaine use disorders and serum magnesium profile. Neuropsychobiology, 2009;59(3):159-64.

    33) Martinotti G, Carli V, Tedeschi D, Di Giannantonio M, Roy A, Janiri L, Sarchiapone M. Mono- and polysubstance dependent subjects differ on social factors, childhood trauma, personality, suicidal behaviour, and comorbid Axis I diagnoses. Additive Behaviors, 2009 Sep;34(9):790-3

    Angelucci F, Ricci V, Martinotti G, Caltagirone C, Bria P. Paliperidone for treatment of obsessive compulsive resistant symptoms in schizophrenia: a case report. Progress Neuropsychopharmacology and Biological Psychiatry. 2009 Oct 1;33(7):1277-8.

    34) Martinotti G, di Nicola M, Frustaci A, Romanelli R, Tedeschi D, Guglielmo R, Guerriero L, Bruschi A, De Filippis R, Pozzi G, Di Giannantonio M, Bria P, Janiri L. Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison tria. Addiction. 2010 Feb;105(2):288-99.

    35) Di Nicola M, Tedeschi D, Mazza M, Martinotti G, Harnic D, Catalano V, Bruschi A, Pozzi G, Bria P, Janiri L. Behavioural addictions in bipolar disorder patients: Role of impulsivity and personality dimensions. Journal Affective Disorders. 2010 Jan 16. [Epub ahead of print]

    36) Mandelli L, Mazza M, Martinotti G, Tavian D, Colombo E, Missaglia S, Di Nicola M, De Ronchi D, Negri G, Colombo R, Janiri L, Serretti A. Further evidence supporting the influence of brain-derived neurotrophic factor on the outcome of bipolar depression: independent effect of brain-derived neurotrophic factor and harm avoidance. Journal Psychopharmacology. 2010 Feb 8. [Epub ahead of print]

    37) Di Nicola M, Martinotti G, Mazza M, Tedeschi D, Pozzi G, Janiri L. Quetiapine as add-on treatment for bipolar I disorder with comorbid compulsive buying and physical exercise addiction. Progress Neuropsychopharmacology and Biological Psychiatry. 2010 May 30;34(4):713-4. Epub 2010 Mar 16

    38) Di Nicola M, Martinotti G, Tedeschi D, Frustaci A, Mazza M, Sarchiapone M, Pozzi G, Bria P, Janiri L. Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome. Human Psychopharmacology. 2010 Apr;25(3):268-75.

    39) Mazza M, Mandelli L, Martinotti G, Di Nicola M, Tavian D, Negri G, Colombo E, Missaglia S, De Ronchi D, Colombo R, Janiri L, Serretti A. Further evidence supporting the association between 5HTR2C gene and bipolar disorder. Psychiatry Research. 2010 May 20. [Epub ahead of print]

    40) Angelucci F, Ricci V, Martinotti G, Palladino I, Spalletta G, Caltagirone C, Bria P. Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms. Addiction Biology.2010 May 11. [Epub ahead of print]

    41) Spalletta G, Morris DW, Angelucci F, Rubino IA, Spoletini I, Bria P, Martinotti G, Siracusano A, Bonaviri G, Bernardini S, Caltagirone C, Bossù P, Donohoe G, Gill M, Corvin AP. BDNF Val66Met polymorphism is associated with aggressive behavior in schizophrenia. European Psychiatry. 2010 Apr 27. [Epub ahead of print]

    42) Mazza M, Mandelli L, Martinotti G, Di Nicola M, Tavian D, Negri G, Colombo E, Missaglia S, De Ronchi D, Colombo R, Janiri L, Serretti A. Further evidence supporting the association between 5HTR2C gene and bipolar disorder. Psychiatry Research 2010 May 20. [Epub ahead of print]

    43) Villella C, Martinotti G, Di Nicola M, Cassano M, La Torre G, Gliubizzi MD, Messeri I, Petruccelli F, Bria P, Janiri L, Conte G. Behavioural Addictions in Adolescents and Young Adults: Results from a Prevalence Study. Journal Gambling Studies. 2010 Jun 18. [Epub ahead of print]

    44) Martinotti G, Reina D, Di Nicola M, Andreoli S, Tedeschi D, Ortolani I, Pozzi G, Iannoni E, D'Iddio S, Janiri L. Acetyl-L-Carnitine for Alcohol Craving and Relapse Prevention in Anhedonic Alcoholics: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial. Alcohol Alcoholism. 2010 Jun 30. [Epub ahead of print]

    45) Spoletini I, Piras F, Fagioli S, Rubino IA, Martinotti G, Siracusano A, Caltagirone C, Spalletta G. Suicidal attempts and increased right amygdala volume in schizophrenia. Schizophrenia Research. 2010 Sep 23. [Epub ahead of print]

    46) De Berardis D, Di Iorio G, Acciavatti T, Conti C, Serroni N, Olivieri L, Cavuto M, Martinotti G, Janiri L, Saverio F, Pio Conti M, Di Giannantonio M. The Emerging Role of Melatonin Agonists in the Treatment of Major Depression: Focus on Agomelatine. CNS Neurological Disorders: Drug Targets. 2010 Sep 29. [Epub ahead of print]

    47) Ricci V, Pomponi M, Martinotti G, Bentivoglio A, Loria G, Bernardini S, Caltagirone C, Bria P, Angelucci F. Antidepressant treatment restores brain-derived neurotrophic factor serum levels and ameliorates motor function in Parkinson disease patients. Journal Clinical Psychopharmacology.2010 Dec;30(6):751-3.

    48) Ricci V, Martinotti G, Gelfo F, Tonioni F, Caltagirone C, Bria P, Angelucci F. Chronic ketamine use increases serum levels of brain-derived neurotrophic factor. Psychopharmacology (Berl). 2010 Dec 14. [Epub ahead of print]

    49) Martinotti G, Ricci V, Di Nicola M, Caltagirone C, Bria P, Angelucci F. Brain-Derived Neurotrophic Factor and Electroconvulsive Therapy in a Schizophrenic Patient With Treatment-Resistant Paranoid-Hallucinatory Symptoms. Journal ECT. 2011 Jan 4. [Epub ahead of print]

    50) Martinotti G, Andreoli S, Reina D, Di Nicola M, Ortolani I, Tedeschi D, Fanella F, Pozzi G, Iannoni E, D'Iddio S, Janiri.L. Acetyl-L-Carnitine in the treatment of anhedonia, melancholic and negative symptoms in alcohol dependent subjects. Progress Neuropsychopharmacol Biol Psychiatry. 2011 Jan 19. [Epub ahead of print]

    51) Martinotti G, Di Iorio G, Tedeschi D, De Berardis D, Niolu C, Janiri L, Di Giannantonio M. Prevalence and intensity of basic symptoms among cannabis users: an observational study. American Journal on Drug and Alcohol Abuse, 2011 Mar;37(2):111-6

    52) Di Giannantonio M, Di Iorio G, Guglielmo R, De Berardis D, Conti CM, Acciavatti T, Cornelio M, Martinotti G. Major depressive disorder, anhedonia and agomelatine: an open-label study Journal Biological Regulators Homeostatic Agents. 2011 Jan-Mar;25(1):109-14.

    53) Addolorato G, Leggio L, Ferrulli A, Cardone S, Bedogni G, Caputo F, Gasbarrini G, Landolfi R; the Baclofen Study Group. Dose-Response Effect of Baclofen in Reducing Daily Alcohol Intake in Alcohol Dependence: Secondary Analysis of A Randomized, Double-Blind, Placebo-Controlled Trial. Alcohol Alcoholism 2011 Mar 17. [Epub ahead of print]

    54) Angelucci F, Martinotti G, Gelfo F, Righino E, Conte G, Caltagirone C, Bria P, Ricci V. Enhanced BDNF serum levels in patients with severe pathological gambling. Addiction Biology. 2011 Nov 1[Epub ahead of print]

    55) Di Nicola M, Tedeschi D, Martinotti G, De Vita O, Monetta M, Pozzi G, Janiri L. Pregabalin augmentation in treatment-resistant obsessive-compulsive disorder:a 16-week case series. Journal Clinical Psychopharmacology. 2011 Oct;31(5):675-7

    56) Picardi A, Martinotti G, Paci M, Simi C, Caroppo E. Reliability of self-reported attachment style in patients with severe psychopathology. Journal Personality Assessment. 2011 Sep-Oct;93(5):491-9.

    57) Mazza M, Mandelli L, Zaninotto L, Nicola MD, Martinotti G, Harnic D, Bruschi A, Catalano V, Tedeschi D, Colombo R, Bria P, Serretti A, Janiri L. Factors associated with the course of symptoms in bipolar disorder during a 1-year follow-up: Depression vs. sub-threshold mixed state. Nordic Journal of Psychiatry. 2011 Dec;65(6):419-26. Epub 2011 Jul 5

    58) Catalano V, Harnic D, Di Nicola M, Mazza M, Martinotti G, Bruschi A, Di Felice C, Carnevale E, Marano G, Pozzi G, Bria P, Janiri L. Diagnosis of deficit and attention/hyperactivity disorders (ADHD) in patients with bipolar or unipolar depression: an experimental study. Clinica terapeutica2011 Mar-Apr;162(2):107-11.

    59) Mazza M, Di Nicola M, Catalano V, Callea A, Martinotti G, Harnic D, Bruschi A, Battaglia C, Janiri L. Description and validation of a questionnaire for the detection of meteoropathy and meteorosensitivity: the METEO-Q. Comprehensive Psychiatry. 2011 Apr 11

    60) Cinosi E, Di Iorio G, Acciavatti T, Cornelio M, Vellante F, De Risio L, Martinotti G. Sleep disturbances in eating disorders: a review. Clin Ter. 2011 Nov;162(6):e195-202.

    61) Carano A, De Berardis D, Campanella D, Serroni N, Ferri F, Di Iorio G, Acciavatti T, Mancini L, Mariani G, Martinotti G, Moschetta FS, Di GiannantonioM. Alexithymia and suicide ideation in a sample of patients with binge eating disorder. J Psychiatr Pract. 2012 Jan;18(1):5-11.

    62) Guglielmo R, Martinotti G, Janiri L. Gabapentin as add-on treatment for somatoform disorder: a case report. Clin Neuropharmacol. 2012 Jan;35(1):45-6.

    63) De Berardis D, Serroni N, Campanella D, Olivieri L, Ferri F, Carano A, CavutoM, Martinotti G, Cicconetti A, Piersanti M, Saverio Moschetta F, Di Giannantonio M. Update On The Adverse Effects Of Clozapine: Focus On Myocarditis. Current Drug Safety. 2012 Feb 1;7(1):55-62.

    64) Innamorati M, Pompili M, Martinotti G, Serafini G, Amore M, Lester D, Girardi P, Janiri L. Trends In Alcohol-Related Deaths In The EU Countries In 1980-2003. International Journal Social Psychiatry. 2012 Apr 16. [Epub Ahead Of Print] Pubmed PMID: 22508718.

    65) Schifano F, Martinotti G, Cunniff A, Reissner V, Scherbaum N, Ghodse H. Impact Of An 18-Month, NHS-Based, Treatment Exposure For Heroin Dependence: Results From The London Area Treat 2000 Study. American Journal Addiction. 2012 May-Jun;21(3):268-73.Epub 2012 Mar 30.

    66) Picardi A, Caroppo E, Porcelli P, Di Maria G, Munittola G, Martinotti G. Alexithymia And Severe Psychopathology: A Study On Psychiatric Inpatients. Psychopathology. 2012;45(3):159-66. Epub 2012 Mar 2.

    67) Mandelli L, Mazza M, Di Nicola M, Zaninotto L, Harnic D, Catalano V, Tedeschi D, Martinotti G, Bria P, Janiri L, Serretti A. Role Of Substance Abuse Comorbidity And Personality On The Outcome Of Depression In Bipolar Disorder: Harm Avoidance Influences Medium-Term Treatment Outcome. Psychopathology. 2012;45(3):174-8

    68) Martinotti G, Sepede G, Gambi F, Di Iorio G, Di Nicola M, Onofry M, Janiri L, Di Giannantonio M. Agomelatine Vs. Venlafaxine For The Treatment Of Anhedonia In Major Depressive Disorder. Journal Clinical Psychopharmacology. In Press

    69) Pomponi M, Janiri L, La Torre G, Di Stasio E, Di Nicola M, Mazza M, Martinotti G, Bria P, Lippa S, Natili R, Pomponi MF. Plasma Levels Of N-3 Fatty Acids In Bipolar Patients: Deficit Restricted To DHA. Journal of Psychiatric Research, Vol. 47

    70) Di Paola M, Luders E, Rubino IA, Siracusano A, Manfredi G, Girardi P, Martinotti G., Thompson PM, Chou YY, Toga AW, Caltagirone C, Spalletta G. (2012). The Structure Of The Corpus Callosum In Obsessive Compulsive Disorder. European Psychiatry, Vol. 27

    71) Martinotti G. Pregabalin In Clinical Psychiatry And Addiction: Pros And Cons. Expert Opinion on Investigational Drugs. 2012 Sep;21(9):1243-5.

    72) Martinotti G., DS. Hatzigiakoumis, O. De Vita, M. Clerici, F. Petruccelli, M. Di Giannantonio, L. Janiri. Anhedonia and reward system: psychobiology, evaluation, and clinical features. International Journal of Clinical Medicine. (3) 2013

    73) Pettorruso M, Martinotti G, Di Nicola M, Onofrj M, Di Giannantonio M, Conte G, Janiri L. Amantadine in the treatment of pathological gambling: a case report. Front Psychiatry. 2012;3:102

    74) Guglielmo R, Martinotti G, Clerici M, Janiri L. Pregabalin for alcohol dependence: a critical review of the literature. Adv Ther. 2012 Nov;29(11):947-57

    75) Di Nicola M, De Risio L, Battaglia C, Camardese G, Tedeschi D, Mazza M, Martinotti G, Pozzi G, Niolu C, Di Giannantonio M, Siracusano A, Janiri L. Reduced hedonic capacity in euthymic bipolar subjects: A trait-like feature? J Affect Disord. 2012 Oct 31

    76) Mazza M, Mandelli L, Zaninotto L, Nicola MD, Martinotti G, Harnic D, Bruschi A, Catalano V, Tedeschi D, Colombo R, Bria P, Serretti A, Janiri L. Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up. Int J Psychiatry Clin Pract. 2012 Jun;16(2):113-20

    77) Martinotti G, Lupi M, Sarchione F, Santacroce R, Salone A, De Berardis D,Serroni N, Cavuto M, Signorelli M, Aguglia E, Valchera A, Iasevoli F, DiGiannantonio M. The potential of pregabalin in neurology, psychiatry andaddiction: a qualitative overview. Curr Pharm Des. 2013 Jun 14.

    78) Di Iorio G, Matarazzo I, Di Tizio L, Martinotti G. Treatment-resistantinsomnia treated with pregabalin. Eur Rev Med Pharmacol Sci. 2013Jun;17(11):1552-4. PubMed PMID: 23771546.

    79) De Berardis D, Marini S, Serroni N, Rapini G, Iasevoli F, Valchera A, Signorelli M, Aguglia E, Perna G, Salone A, Di Iorio G, Martinotti G, Di Giannantonio M. S-Adenosyl-L-Methionine Augmentation in Patients with Stage II Treatment-Resistant Major Depressive Disorder: An Open Label, Fixed Dose, Single-Blind Study. ScientificWorldJournal. 2013 May

    80) De Berardis D, Marini S, Fornaro M, Srinivasan V, Iasevoli F, Tomasetti C, Valchera A, Perna G, Quera-Salva MA, Martinotti G, di Giannantonio M. The melatonergic system in mood and anxiety disorders and the role of agomelatine:implications for clinical practice. Int J Mol Sci. 2013 Jun 13;14(6):12458-83.

    81) De Berardis D, Serroni N, Marini S, Rapini G, Valchera A, Fornaro M, Mazza M, Iasevoli F, Martinotti G, Di Giannantonio M. Successful ziprasidone monotherapyin a case of delusional parasitosis: a one-year followup. Case Rep Psychiatry.

    82) De Berardis D, Conti CM, Marini S, Ferri F, Iasevoli F, Valchera A, Fornaro M, Cavuto M, Srinivasan V, Perna G, Carano A, Piersanti M, Martinotti G, Di Giannantonio M. Is there a role for agomelatine in the treatment of anxiety disorders? a review of published data. Int J Immunopathol Pharmacol. 2013Apr-Jun;26(2):299-304.

    83) De Berardis D, Serroni N, Moschetta FS, Martinotti G, Di Giannantonio M. Reversal of aripiprazole-induced tardive akathisia by addition of pregabalin. JNeuropsychiatry Clin Neurosci. 2013 Mar 1;25(2):E09-10.

    84) Martinotti G, Di Nicola M, Tedeschi D, Callea A, Di Giannantonio M, Janiri L; Craving Study Group. Craving Typology Questionnaire (CTQ): A scale for alcohol craving in normal controls and alcoholics. Compr Psychiatry. 2013 May 2.

    85) De Berardis D, Valchera A, Fornaro M, Serroni N, Marini S, Moschetta FS,Martinotti G, Di Giannantonio M. Agomelatine reversal of escitalopram-inducedapathy: a case report. Psychiatry Clin Neurosci. 2013 Apr;67(3):190-1.

    86) Martinotti G, Sepede G, Signorelli M, Aguglia E, Di Giannantonio M. Efficacy and safety of fluoxetine monotherapy in bipolar depression: a systematic review. Expert Opin Pharmacother. 2013 Jun;14(8):1065-75.

    87) Guglielmo R, Martinotti G, Di Giannantonio M, Janiri L. A possible new option for migraine management: agomelatine. Clin Neuropharmacol. 2013 Mar-Apr;36(2):65-7.

    88) De Berardis D, Marini S, Iasevoli F, Tomasetti C, de Bartolomeis A, Mazza M, Valchera A, Fornaro M, Cavuto M, Srinivasan V, Sepede G, Martinotti G, Di Giannantonio M. The role of intranasal oxytocin in the treatment of patients with schizophrenia: a systematic review. CNS Neurol Disord Drug Targets. 2013Mar;12(2):252-64.

    89) Fornaro M, Ventriglio A, De Pasquale C, Pistorio ML, De Berardis D, Cattaneo CI, Favaretto E, Martinotti G, Tomasetti C, Elassy M, D'Angelo E, Mungo S, DelDebbio A, Romano A, Ciampa G, Colicchio S. Sensation seeking in major depressive patients: relationship to sub-threshold bipolarity and cyclothymic temperament. JAffect Disord. 2013 Jun;148(2-3):375-83.

    90) De Berardis D, Marini S, Carano A, Lang AP, Cavuto M, Piersanti M, Fornaro M, Perna G, Valchera A, Mazza M, Iasevoli F, Martinotti G, Di Giannantonio M. Efficacy and Safety of Long Acting Injectable Atypical Antipsychotics: A Review. Curr Clin Pharmacol. 2013 Jan 4.

    91) Sepede G, Martinotti G, Gambi F, Salerno RM, Di Giannantonio M. Lamotrigineaugmentation in premenstrual dysphoric disorder: a case report. ClinNeuropharmacol. 2013 Jan-Feb;36(1):31-3.

    92) De Berardis D, Marini S, Iasevoli F, Tomasetti C, de Bartolomeis A, Mazza M, Valchera A, Fornaro M, Cavuto M, Srinivasan V, Sepede G, Martinotti G, Di Giannantonio M. The role of intranasal oxytocin in the treatment of patients with schizophrenia: a systematic review. CNS Neurol Disord Drug Targets. 2013 Mar.

    93) Guglielmo R, Martinotti G, Di Giannantonio M, Janiri L. A possible new option for migraine management: agomelatine. Clin Neuropharmacol. 2013 Mar-Apr.

    94) De Berardis D, Valchera A, Fornaro M, Serroni N, Marini S, Moschetta FS, Martinotti G, Di Giannantonio M. Agomelatine reversal of escitalopram-induced apathy: a case report. Psychiatry Clin Neurosci. 2013 Apr.

    95) De Berardis D, Conti CM, Marini S, Ferri F, Iasevoli F, Valchera A, Fornaro M, Cavuto M, Srinivasan V, Perna G, Carano A, Piersanti M, Martinotti G, Di Giannantonio M. Is there a role for agomelatine in the treatment of anxiety disorders? a review of published data. Int J Immunopathol Pharmacol. 2013 Apr-Jun.

    96) De Berardis D, Marini S, Serroni N, Rapini G, Iasevoli F, Valchera A, Signorelli M, Aguglia E, Perna G, Salone A, Di Iorio G, Martinotti G, Di Giannantonio M. S-Adenosyl-L-Methionine augmentation in patients with stage II treatment-resistant major depressive disorder: an open label, fixed dose, single-blind study. ScientificWorldJournal. 2013 May 12.

    97) De-Giorgio F, Grassi VM, Chillemi E, Martinotti G. Dead under the bed: a case of Diogenes syndrome? Int J Geriatr Psychiatry. 2013 May.

    98) Fornaro M, Ventriglio A, De Pasquale C, Pistorio ML, De Berardis D, Cattaneo CI, Favaretto E, Martinotti G, Tomasetti C, Elassy M, D'Angelo E, Mungo S, Del Debbio A, Romano A, Ciampa G, Colicchio S. Sensation seeking in major depressive patients: relationship to sub-threshold bipolarity and cyclothymic temperament. J Affect Disord. 2013 Jun.

    99) Di Iorio G, Matarazzo I, Di Tizio L, Martinotti G. Treatment-resistant insomnia treated with pregabalin. Eur Rev Med Pharmacol Sci. 2013 Jun.

    100) Martinotti G, Sepede G, Signorelli M, Aguglia E, Di Giannantonio M. Efficacy and safety of fluoxetine monotherapy in bipolar depression: a systematic review. Expert Opin Pharmacother. 2013 Jun.

    101) De Berardis D, Marini S, Fornaro M, Srinivasan V, Iasevoli F, Tomasetti C, Valchera A, Perna G, Quera-Salva MA, Martinotti G, di Giannantonio M. The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice. Int J Mol Sci. 2013 Jun 13.

    102) De Berardis D, Campanella D, Serroni N, Moschetta FS, Di Emidio F, Conti C, Carano A, Acciavatti T, Di Iorio G, Martinotti G, Siracusano A, Di Giannantonio M. Alexithymia, suicide risk and serum lipid levels among adult outpatients with panic disorder. Compr Psychiatry. 2013 Jul;54(5):517-22.

    103) Ferri F, Costantini M, Salone A, Di Iorio G, Martinotti G, Chiarelli A, Merla A, Di Giannantonio M, Gallese V. Upcoming tactile events and body ownership in schizophrenia. Schizophr Res. 2013 Jul 5.

    104) De Berardis D, Marini S, Carano A, Lang AP, Cavuto M, Piersanti M, Fornaro M, Perna G, Valchera A, Mazza M, Iasevoli F, Martinotti G, Di Giannantonio M. Efficacy and safety of long acting injectable atypical antipsychotics: a review. Curr Clin Pharmacol. 2013 Aug.

    105) Di Nicola M, Sala L, Romo L, Catalano V, Even C, Dubertret C, Martinotti G, Camardese G, Mazza M, Tedeschi D, Callea A, De Risio L, Guelfi JD, Rouillon F, Janiri L, Gorwood P. Adult attention-deficit/hyperactivity disorder in major depressed and bipolar subjects: role of personality traits and clinical implications. Eur Arch Psychiatry Clin Neurosci. 2013 Sep 28.

    106) Picardi A, Caroppo E, Fabi E, Proietti S, Di Gennaro G, Meldolesi GN, Martinotti G. Attachment and parenting in adult patients with anxiety disorders. Clin Pract Epidemiol Ment Health. 2013 Oct 4;9:157-63

    107) Vellante F, Cornelio M, Acciavatti T, Cinosi E, Marini S, Dezi S, De Risio L, Di Iorio G, Martinotti G, Di Giannantonio M. Treatment of resistant insomnia and major depression. Clin Ter. 2013;164(5):429-35

    108) De Berardis D, Fornaro M, Serroni N, Olivieri L, Marini S, Moschetta FS,Srinivasan V, Assetta M, Valchera A, Salone A, Martinotti G, Onofrj M, DiGiannantonio M. Agomelatine treatment of major depressive disorder in Parkinson's disease: a case series. J Neuropsychiatry Clin Neurosci. 2013 Oct 1;25(4):343-5

    109) Iasevoli F, Valchera A, Di Giovambattista E, Marconi M, Rapagnani MP, DeBerardis D, Martinotti G, Fornaro M, Mazza M, Tomasetti C, Buonaguro EF, Di Giannantonio M, Perugi G, de Bartolomeis A. Affective temperaments are associated with specific clusters of symptoms and psychopathology: a cross-sectional study on bipolar disorder inpatients in acute manic, mixed, or depressive relapse. J Affect Disord. 2013 Nov;151(2):540-50

    110) Angelucci F, Ricci V, Gelfo F, Martinotti G, Brunetti M, Sepede G, Signorelli M, Aguglia E, Pettorruso M, Vellante F, Di Giannantonio M, Caltagirone C. BDNF serum levels in subjects developing or not post-traumatic stress disorder after trauma exposure. Brain Cogn. 2013 Dec 18;84(1):118-122

    111) De Berardis D, Fornaro M, Serroni N, Marini S, Piersanti M, Cavuto M, Valchera A, Mazza M, Girinelli G, Iasevoli F, Perna G, Martinotti G, Di Giannantonio M. Treatment of antipsychotic-induced hyperprolactinemia: an update on the role of the dopaminergic receptors d2 partial agonist aripiprazole. Recent Pat Endocr Metab Immune Drug Discov. 2014 Jan;8(1):30-7.

    112) Pettorruso M, Martinotti G, Fasano A, Loria G, Di Nicola M, De Risio L, Ricciardi L, Conte G, Janiri L. Bentivoglio AR. Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study. Psychiatry Res. 2014 Feb 28;215(2):448-52.

    113) Sepede G, Di lorio G, Lupi M, Sarchione F, Acciavatti T, Fiori F, Santacroce R, Martinotti G, Gambi F, Di Giannantonio M. Bupropion as an add-on therapy in depressed bipolar disorder type I patients with comorbid cocaine dependence. Clin Neuropharmacol. 2014 Jan-Feb;37(1):17-21.

    114) De Berardis D, Brucchi M, Serroni N, Valchera A, Fornaro M, Mazza M, Martinotti G, Di Giannantonio M. Successful use of agomelatine in the treatment of major depression in a woman taking tamoxifen: a case report. Clin Neuropharmacol. 2014 Jan-Feb;37(1):31-3.

    115) De Berardis D, Serroni N, Marini S, Rapini G, Carano A, Valchera A, Iasevoli F, Mazza M, Signorelli M, Aguglia E, Perna G, Martinotti G, Varasano PA,Pressanti GL, Di Giannantonio M. Alexithymia, suicidal ideation, and serum lipid levels among drug-naïve outpatients with obsessive-compulsive disorder. Rev Bras Psiquiatr. 2014 Jan 17;0:0. [Epub ahead of print]

    116) Iasevoli F, Buonaguro EF, Marconi M, Di Giovambattista E, Rapagnani MP, De Berardis D, Martinotti G, Mazza M, Balletta R, Serroni N, Di Giannantonio M, de Bartolomeis A, Valchera A. Efficacy and clinical determinants of antipsychotic polypharmacy in psychotic patients experiencing an acute relapse and admitted to hospital stay: results from a cross-sectional and a subsequent longitudinal pilot study. ISRN Pharmacol. 2014 Jan 27;2014:762127.

    117) Corazza O, Bersani FS, Brunoro R, Valeriani G, Martinotti G, Schifano F. The diffusion of Performance and Image-Enhancing Drugs (PIEDs) on the Internet: The Abuse of the Cognitive Enhancer Piracetam. Subst Use Misuse. 2014 Dec 6;49(14):1849-56. doi: 10.3109/10826084.2014.912232.

    118) DE Berardis D, Serroni N, Marini S, Fornaro M, Valchera A, Martinotti G, DI Giannantonio M, Kahn DA. Emerging mania following escitalopram withdrawal in a patient with unipolar depression managed with its reintroduction. J Psychiatr Pract. 2014 May;20(3):228-31.

    119) Lupi M, Martinotti G, Acciavatti T, Pettorruso M, Brunetti M, Santacroce R, Cinosi E, Di Iorio G, Di Nicola M, Di Giannantonio M. Pharmacological treatments in gambling disorder: a qualitative review. Biomed Res Int. 2014;2014:537306.

    120) Cera N, Bifolchetti S, Martinotti G, Gambi F, Sepede G, Onofrj M, Di Giannantonio M, Thomas A. Amantadine and cognitive flexibility: decision making in Parkinson's patients with severe pathological gambling and other impulse control disorders. Neuropsychiatr Dis Treat. 2014 Jun 17;10:1093-101.

    121) Di Iorio G, Lupi M, Sarchione F, Matarazzo I, Santacroce R, Petruccelli F, Martinotti G, Di Giannantonio M. The endocannabinoid system: a putative role in neurodegenerative diseases. Int J High Risk Behav Addict. 2013 Dec;2(3):100-6.

    122) De Berardis D, Mazza M, Marini S, Del Nibletto L, Serroni N, Pino MC, Valchera A, Ortolani C, Ciarrocchi F, Martinotti G, Di Giannantonio M. Psychopathology, emotional aspects and psychological counselling in infertility: a review. Clin Ter. 2014;165(3):163-9.

    123) Di Nicola M, De Risio L, Pettorruso M, Caselli G, De Crescenzo F, Swierkosz-Lenart K, Martinotti G, Camardese G, Di Giannantonio M, Janiri L. Bipolar disorder and gambling disorder comorbidity: current evidence and implications for pharmacological treatment. J Affect Disord. 2014 Oct;167:285-98.

    124) De Berardis D, Campanella D, Serroni N, Rapini G, Olivieri L, Fornaro M, Valchera A, Iasevoli F, Napoletano C, Martinotti G, Giannantonio MD. Clozapine-related pericarditis during titration phase in a patient with resistant schizophrenia and concomitant valproate treatment: a case report. J Clin Psychopharmacol. 2014 Oct;34(5):649-51.

    125) Alessandri G, Fagnani C, Di Gennaro G, Meldolesi GN, Pasquini P, Caroppo E, Martinotti G, Toni A, Fabi E, Picardi A. Measurement invariance of the experiences in close relationships questionnaire across different populations. Span J Psychol. 2014 Jan;17:E22.

    126) Pettorruso M, De Risio L, Martinotti G, Di Nicola M, Ruggeri F, Conte G, Di Giannantonio M, Janiri L. Targeting the glutamatergic system to treat pathological gambling: current evidence and future perspectives. Biomed Res Int. 2014;2014:109786.

    127) Corazza O, Martinotti G, Santacroce R, Chillemi E, Di Giannantonio M, Schifano F, Cellek S. Sexual enhancement products for sale online: raising awareness of the psychoactive effects of yohimbine, maca, horny goat weed, and Ginkgo biloba. Biomed Res Int. 2014;2014:841798.

    128) Petruccelli F, Diotaiuti P, Verrastro V, Petruccelli I, Federico R, Martinotti G, Fossati A, Di Giannantonio M, Janiri L. Affective dependence and aggression: an exploratory study. Biomed Res Int. 2014;2014:805469.

    129) Petruccelli F, Diotaiuti P, Verrastro V, Petruccelli I, Carenti ML, De Berardis D, Iasevoli F, Valchera A, Fornaro M, Martinotti G, Di Giannantonio M, Janiri L. Obsessive-compulsive aspects and pathological gambling in an Italian sample. Biomed Res Int. 2014;2014:167438.

    130) Bersani FS, Corazza O, Albano G, Valeriani G, Santacroce R, Bolzan Mariotti Posocco F, Cinosi E, Simonato P, Martinotti G, Bersani G, Schifano F. 25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug. Biomed Res Int. 2014;2014:734749.

    131) Martinotti G, Lupi M, Acciavatti T, Cinosi E, Santacroce R, Signorelli MS, Bandini L, Lisi G, Quattrone D, Ciambrone P, Aguglia A, Pinna F, Calò S, Janiri L, di Giannantonio M. Novel psychoactive substances in young adults with and without psychiatric comorbidities. Biomed Res Int. 2014;2014:815424.

    132) Cinosi E, Corazza O, Santacroce R, Lupi M, Acciavatti T, Martinotti G, di Giannantonio M. New drugs on the Internet: the case of Camfetamine. Biomed Res Int. 2014;2014:419026.

    133) Corazza O, Valeriani G, Bersani FS, Corkery J, Martinotti G, Bersani G, Schifano F. "Spice," "kryptonite," "black mamba": an overview of brand names and marketing strategies of novel psychoactive substances on the web. J Psychoactive Drugs. 2014 Sep-Oct;46(4):287-94.

    134) Vento AE, Martinotti G, Cinosi E, Lupi M, Acciavatti T, Carrus D, Santacroce R, Chillemi E, Bonifaci L, di Giannantonio M, Corazza O, Schifano F. Substance use in the club scene of Rome: a pilot study. Biomed Res Int. 2014;2014:617546.

    135) Martinotti G, Di Nicola M, De Vita O, Hatzigiakoumis DS, Guglielmo R, Santucci B, Aliotta F, Romanelli R, Verrastro V, Petruccelli F, Di Giannantonio M, Janiri L. Low-dose topiramate in alcohol dependence: a single-blind, placebo-controlled study. J Clin Psychopharmacol. 2014 Dec;34(6):709-15.

    136) Fornaro M, De Berardis D, De Pasquale C, Indelicato L, Pollice R, Valchera A, Perna G, Iasevoli F, Tomasetti C, Martinotti G, Koshy AS, Fasmer OB, Oedegaard KJ. Prevalence and clinical features associated to bipolar disorder-migraine comorbidity: a systematic review. Compr Psychiatry. 2015 Jan;56C:1-16.

    137) Galderisi S, Rossi A, Rocca P, Bertolino A, Mucci A, Bucci P, Rucci P, Gibertoni D, Aguglia E, Amore M, Bellomo A, Biondi M, Brugnoli R, Dell'Osso L, De Ronchi D, Di Emidio G, Di Giannantonio M, Fagiolini A, Marchesi C, Monteleone P, Oldani L, Pinna F, Roncone R, Sacchetti E, Santonastaso P, Siracusano A, Vita A, Zeppegno P, Maj M; Italian Network For Research on Psychoses. The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia. World Psychiatry. 2014 Oct;13(3):275-87.

    138) Pettorruso M, De Risio L, Di Nicola M, Martinotti G, Conte G, Janiri L. Allostasis as a conceptual framework linking bipolar disorder and addiction. Front Psychiatry. 2014 Dec 3;5:173.

    139) De Berardis D, Fornaro M, Serroni N, Campanella D, Rapini G, Olivieri L, Srinivasan V, Iasevoli F, Tomasetti C, De Bartolomeis A, Valchera A, Perna G, Mazza M, Di Nicola M, Martinotti G, Di Giannantonio M. Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression. Int J Mol Sci. 2015 Jan 5;16(1):1111-30.

    140) De Berardis D, Serroni N, Campanella D, Rapini G, Olivieri L, Feliziani B, Carano A, Valchera A, Iasevoli F, Tomasetti C, Mazza M, Fornaro M, Perna G, Di Nicola M, Martinotti G, Di Giannantonio M. Alexithymia, responsibility attitudes and suicide ideation among outpatients with obsessive-compulsive disorder: an exploratory study. Compr Psychiatry. 2015 Apr;58:82-7.

    141) Martinotti G, Corazza O, Achab S, Demetrovics Z. Novel psychoactive substances
    and behavioral addictions. Biomed Res Int. 2014;2014:534523.

    142) De Berardis D, Conti C, Iasevoli F, Valchera A, Fornaro M, Cavuto M, Brucchi M, Perna G, Pompili M, Modabbernia A, Lucidi G, Mazza M, Martinotti G, Di Giannantonio M. Alexithymia and its relationships with acute phase proteins and cytokine release: an updated review. J Biol Regul Homeost Agents. 2014 Oct-Dec;28(4):795-9.

    143) Di Nicola M, Tedeschi D, De Risio L, Pettorruso M, Martinotti G, Ruggeri F, Swierkosz-Lenart K, Guglielmo R, Callea A, Ruggeri G, Pozzi G, Di Giannantonio M, Janiri L. Co-occurrence of alcohol use disorder and behavioral addictions: relevance of impulsivity and craving. Drug Alcohol Depend. 2015 Mar 1;148:118-25.

    144) Signorelli MS, Cinconze M, Nasca MR, Marino M, Martinotti G, Di Giannantonio M, Aguglia E. Can topiramate induce pruritus? A case report and review of literature. CNS Neurol Disord Drug Targets. 2015;14(3):309-12.

    145) Fornaro M, De Berardis D, Mazza M, Pino M, Favaretto E, Bedani F, Wieser C, Indelicato L, Paternò VF, Lo Monaco F, Dugo F, Ventriglio A, Mungo S, Selle V, Valchera A, Elassy M, Martinotti G, De Bartolomeis A, Iasevoli F, Tomasetti C, Avvisati L, Tartaglione S, Perna G, Cattaneo CI, Consoli G, Romano A, Del Debbio A, Martino M, D׳Angelo E, De Pasquale C, Koshy AS, Angst J. Factor structure and reliability of the Italian adaptation of the Hypomania Check List-32, second revision (HCL-32-R2). J Affect Disord. 2015 Jun 1;178:112-120.

    146) De Berardis D, Serroni N, Campanella D, Marini S, Rapini G, Valchera A, Iasevoli F, Mazza M, Fornaro M, Perna G, Di Iorio G, Martinotti G, Di Giannantonio M. Alexithymia, Suicide Ideation, C-Reactive Protein and Serum Lipid Levels among Outpatients with Generalized Anxiety Disorder. Arch Suicide Res. 2015 Apr 9.

    147) Guglielmo R, Martinotti G, Quatrale M, Ioime L, Kadilli I, Di Nicola M, Janiri L. Topiramate in Alcohol Use Disorders: Review and Update. CNS Drugs. 2015 Apr 22..

    148) De Berardis D, Marini S, Serroni N, Iasevoli F, Tomasetti C, Bartolomeis A, Mazza M, Tempesta D, Valchera A, Fornaro M, Pompili M, Sepede G, Vellante F, Orsolini L, Martinotti G, Giannantonio MD. Targeting The Noradrenergic System In Posttraumatic Stress Disorder: A Systematic Review And Meta-Analysis Of Prazosin Trials. Curr Drug Targets. 2015 May 6

    149) De Berardis D, Brucchi M, Serroni N, Rapini G, Campanella D, Vellante F, Valchera A, Fornaro M, Iasevoli F, Mazza M, Lucidi G, Martinotti G, di Giannantonio M. Cotard's Syndrome after breast surgery successfully treated with aripiprazole augmentation of escitalopram: a case report. Riv Psichiatr. 2015 Mar-Apr;50(2):95-8.

    150) Pettorruso M, Di Nicola M, De Risio L, Fasano A, Martinotti G, Conte G, Bentivoglio AR, Janiri L. Punding behavior in bipolar disorder type 1: case report. J Neuropsychiatry Clin Neurosci. 2014 Fall;26(4):E8-9.

    151) Bersani FS, Corazza O, Albano G, Bruschi S, Minichino A, Vicinanza R, Bersani G, Martinotti G, Schifano F. The "Eyeballing" technique: an emerging and alerting trend of alcohol misuse. Eur Rev Med Pharmacol Sci. 2015 Jun;19(12):2311-7.

    152) Santacroce R, Corazza O, Martinotti G, Bersani FS, Valeriani G, Di Giannantonio M. Psyclones: a roller coaster of life? Hidden synthetic cannabinoids and stimulants in apparently harmless products. Hum Psychopharmacol. 2015 Jul;30(4):265-71.

    153) Martinotti G, Lupi M, Carlucci L, Cinosi E, Santacroce R, Acciavatti T, Chillemi E, Bonifaci L, Janiri L, Di Giannantonio M. Novel psychoactive substances: use and knowledge among adolescents and young adults in urban and rural areas. H Psychopharmacol. 2015 Jul;30(4):295-301.

    154) Dell'Osso B, Albert U, Atti AR, Carmassi C, Carrà G, Cosci F, Del Vecchio V, Di Nicola M, Ferrari S, Goracci A, Iasevoli F, Luciano M, Martinotti G, Nanni MG, Nivoli A, Pinna F, Poloni N, Pompili M, Sampogna G, Tarricone I, Tosato S, Volpe U, Fiorillo A. Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice. Neuropsychiatr Dis Treat. 2015 Jul 30;11:1885-909.

    155) Martinotti G, Sepede G, Brunetti M, Ricci V, Gambi F, Chillemi E, Vellante F, Signorelli M, Pettorruso M, De Risio L, Aguglia E, Angelucci F, Caltagirone C, Di Giannantonio M. BDNF concentration and impulsiveness level in post-traumatic stress disorder. Psychiatry Res. 2015 Oct 30;229(3):814-8.

    156) De Berardis D, Orsolini L, Serroni N, Girinelli G, Iasevoli F, Tomasetti C, de Bartolomeis A, Mazza M, Valchera A, Fornaro M, Perna G, Piersanti M, Di Nicola M, Cavuto M, Martinotti G, Di Giannantonio M. A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder. CNS Neurol Disord Drug Targets. 2016;15(1):35-44.

    157) De Risio L, Pettorruso M, Di Nicola M, Martinotti G, Janiri L, Fasano A. Management of aripiprazole-induced tardive Pisa syndrome: a case report and literature review. Int Clin Psychopharmacol. 2016 Jan;31(1):57-60.

    158) Marini S, Di Tizio L, Dezi S, Armuzzi S, Pelaccia S, Valchera A, Sepede G, Girinelli G, De Berardis D, Martinotti G, Gambi F, Di Giannantonio M. The bridge between two worlds: psychoanalysis and fMRI. Rev Neurosci. 2016 Feb 1;27(2):219-29.

    159) Nosè M, Bighelli I, Castellazzi M, Martinotti G, Carrà G, Lucii C, Ostuzzi G, Sozzi F, Barbui C; STAR NETWORK GROUP. Prevalence and correlates of QTc prolongation in Italian psychiatric care: cross-sectional multicentre study.Epidemiol Psychiatr Sci. 2015 Oct 15:1-9.

    160) Cinosi E, Martinotti G, Simonato P, Singh D, Demetrovics Z, Roman-Urrestarazu A, Bersani FS, Vicknasingam B, Piazzon G, Li JH, Yu WJ, Kapitány-Fövény M, Farkas J, Di Giannantonio M, Corazza O. Following "the Roots" of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries. Biomed Res Int. 2015; 2015: 968786.

    161) Marini S, Vellante F, Matarazzo I, De Berardis D, Serroni N, Gianfelice D, Olivieri L, Di Renzo F, Di Marco A, Fornaro M, Orsolini L, Valchera A, Iasevoli F, Mazza M, Perna G, Martinotti G, Di Giannantonio M. Inflammatory markers and suicidal attempts in depressed patients: A review. Int J Immunopathol Pharmacol. 2016 Jan 4. pii: 0394632015623793.

    162) Martinotti G, Pettorruso M, De Berardis D, Varasano PA, Lucidi Pressanti G, De Remigis V, Valchera A, Ricci V, Di Nicola M, Janiri L, Biggio G, Di Giannantonio M. Agomelatine Increases BDNF Serum Levels in Depressed Patients in Correlation with the Improvement of Depressive Symptoms. Int J Neuropsychopharmacol. 2016 Jan16.

    163) Barbui C, Bighelli I, Carrà G, Castellazzi M, Lucii C, Martinotti G, Nosè M, Ostuzzi G; STAR NETWORK INVESTIGATORS. Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval. PLoS One. 2016 Feb 3;11(2):e0148212.

    164) Salone A, Di Giacinto A, Lai C, De Berardis D, Iasevoli F, Fornaro M, De Risio L, Santacroce R, Martinotti G, Giannantonio MD. The Interface between Neuroscience and Neuro-Psychoanalysis: Focus on Brain Connectivity. Front Hum Neurosci. 2016 Feb 3;10:20.

    165) Pettorruso M, Fasano A, De Risio L, Ricciardi L, Di Nicola M, Martinotti G, Janiri L, Bentivoglio AR. Punding in non-demented Parkinson's disease patients: Relationship with psychiatric and addiction spectrum comorbidity. J Neurol Sci. 2016 Mar 15;362:344-7.

    166) Orsolini L, Tomasetti C, Valchera A, Iasevoli F, Buonaguro EF, Vellante F, Fornaro M, Fiengo A, Mazza M, Vecchiotti R, Perna G, de Bartolomeis A, Martinotti G, Di Giannantonio M, De Berardis D. New advances in the treatment of generalized anxiety disorder: the multimodal antidepressant vortioxetine. Expert Rev Neurother. 2016 May;16(5):483-95.

    167) Martinotti G, Orsolini L, Fornaro M, Vecchiotti R, De Berardis D, Iasevoli F, Torrens M, Di Giannantonio M. Aripiprazole for relapse prevention and craving in alcohol use disorder: current evidence and future perspectives. Expert OpinInvestig Drugs. 2016 Apr 21:1-10

    168) Luciano M, Sampogna G, Del Vecchio V, De Rosa C, Albert U, Carrà G, Dell'Osso B, Lorenzo GD, Ferrari S, Martinotti G, Nanni MG, Pinna F, Pompili M, Volpe U, Catapano F, Fiorillo A. [Critical evaluation of current diagnostic classification systems in psychiatry: the case of DSM-5]. Riv Psichiatr. 2016 May-Jun;51(3):116-21

    169) De Berardis D, Orsolini L, Iasevoli F, Prinzivalli E, de Bartolomeis A, Serroni N, Mazza M, Valchera A, Fornaro M, Vecchiotti R, Carano A, Sepede G, Vellante F, Matarazzo I, Pompili M, Perna G, Conti C, Segura-García C, Martinotti G, Di Giannantonio M. The Novel Antipsychotic Cariprazine (RGH-188): State-of-the-Art in the Treatment of Psychiatric Disorders. Curr Pharm Des. 2016;22(33): 5144-5162

    170) Marini S, De Berardis D, Vellante F, Santacroce R, Orsolini L, Valchera A, Girinelli G, Carano A, Fornaro M, Gambi F, Martinotti G, Di Giannantonio M. Celecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On Trials. Mediators Inflamm. 2016;2016: 3476240

    171) Martinotti G, Lupi M, Carlucci L, Santacroce R, Cinosi E, Acciavatti T, Sarchione F, Verrastro V, Diotaiuti P, Petruccelli I, Ferrari S, Nanni MG, Pinna F, Volpe U, Saggino A, Janiri L, Leggio L, Di Giannantonio M. Alcohol drinking patterns in young people: A survey-based study. J Health Psychol. 2016 Sep 13

    172) De Berardis D, Fornaro M, Orsolini L, Iasevoli F, Tomasetti C, de Bartolomeis A, Serroni N, De Lauretis I, Girinelli G, Mazza M, Valchera A, Carano A, Vellante F, Matarazzo I, Perna G, Martinotti G, Di Giannantonio M. Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in "real-world," everyday clinical practice CNS Spectr. 2016 Oct 5:1-6

    173) Al-Imam A, Santacroce R, Roman-Urrestarazu A, Chilcott R, Bersani G, Martinotti G, Corazza O. Captagon: use and trade in the Middle East. Hum Psychopharmacol. 2016 Oct 21

    174) Orsolini L, Tomasetti C, Valchera A, Iasevoli F, Buonaguro EF, Fornaro M, Fiengo AL, Martinotti G, Vellante F, Matarazzo I, Vecchiotti R, Perna G, Di Nicola M, Carano A, de Bartolomeis A, Di Giannantonio M, De Berardis D. Current and future perspectives on the Major Depressive Disorder: Focus on the new multimodal antidepressant Vortioxetine. CNS Neurol Disord Drug Targets. 2016

    175) Nosè M, Bighelli I, Castellazzi M, Martinotti G, Carrà G, Lucii C, Ostuzzi G, Sozzi F, Barbui C; STAR NETWORK GROUP.. Prevalence and correlates of QTc prolongation in Italian psychiatric care: cross-sectional multicentre study. Epidemiol Psychiatr Sci. 2016 Dec;25(6):532-540

    176) Gargoloff PD, Corral R, Herbst L, Marquez M, Martinotti G, Gargoloff PR. Effectiveness of agomelatine on anhedonia in depressed patients: an outpatient, open-label, real-world study. Hum Psychopharmacol. 2016 Nov;31(6):412-418.

    177) Acciavatti T, Martinotti G, Corbo M, Cinosi E, Lupi M, Ricci F, Di Scala R, D'Ugo E, De Francesco V, De Caterina R, di Giannantonio M. Psychotropic drugs and ventricular repolarisation: The effects on QT interval, T-peak to T-end interval and QT dispersion. J Psychopharmacol. 2017 Apr;31(4):453-460.

    178) Tomasetti C, Iasevoli F, Buonaguro EF, De Berardis D, Fornaro M, Fiengo AL, Martinotti G, Orsolini L, Valchera A, Di Giannantonio M, de Bartolomeis A. Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions. Int J Mol Sci. 2017 Jan 12;18(1).

    179) De Berardis D, Fornaro M, Orsolini L, Iasevoli F, Tomasetti C, de Bartolomeis A, Serroni N, Valchera A, Carano A, Vellante F, Marini S, Piersanti M, Perna G, Martinotti G, Di Giannantonio M. The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review. Int J Mol Sci. 2017 Feb 8;18(2).

    180) Lupi M, Martinotti G, Santacroce R, Cinosi E, Carlucci M, Marini S, Acciavatti T, di Giannantonio M. Transcranial Direct Current Stimulation in Substance Use Disorders: A Systematic Review of Scientific Literature. J ECT. 2017 Mar 8.

    181) Brunetti M, Marzetti L, Sepede G, Zappasodi F, Pizzella V, Sarchione F, Vellante F, Martinotti G, Di Giannantonio M. Resilience and cross-network connectivity: A neural model for post-trauma survival. Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jul 3;77:110-119.

    182) Martinotti G, Santacroce R, Papanti D, Elgharably Y, Prilutskaya M, Corazza O. Synthetic Cannabinoids: psychopharmacology, clinical aspects, and psy-chotic onset. CNS Neurol Disord Drug Targets. 2017 Apr 13.

    183) Moccia L, Pettorruso M, De Crescenzo F, De Risio L, di Nuzzo L, Martinotti G, Bifone A, Janiri L, Di Nicola M. Neural correlates of cognitive control in gambling disorder: a systematic review of fMRI studies. Neurosci Biobehav Rev. 2017 Jul;78:104-116.

    184) Janiri D, Di Nicola M, Martinotti G, Janiri L. Who's the Leader, Mania or Depression? Predominant Polarity and Alcohol/Polysubstance Use in Bipolar Disorders. Curr Neuropharmacol. 2017 Apr;15(3):409-416.

    185) Acciavatti T, Lupi M, Santacroce R, Aguglia A, Attademo L, Bandini L, Ciambrone P, Lisi G, Migliarese G, Pinna F, Quattrone D, Ribolsi M, Signorelli MS, Calò S, Schifano F, di Giannantonio M, Martinotti G. Novel psychoactive substance consumption is more represented in bipolar disorder than in psychotic disorders: A multicenter-observational study. Hum Psychopharmacol. 2017 May;32(3).

    186) Sala L, Martinotti G, Carenti ML, Romo L, Oumaya M, Pham-Scottez A, Rouillon F, Gorwood P, Janiri L. Attention-deficit/hyperactivity disorder symptoms and psychological comorbidity in eating disorder patients. Eat Weight Disord. 2017 May 22.

    187) Di Nicola M, De Filippis S, Martinotti G, De Risio L, Pettorruso M, De Persis S, Maremmani AGI, Maremmani I, di Giannantonio M, Janiri L. Nalmefene in Alcohol Use Disorder Subjects with Psychiatric Comorbidity: A Naturalistic Study. Adv Ther. 2017 Jul;34(7):1636-1649.

    188) Santacroce R, Martinotti G, di Giannantonio M. The light at the end of the tunnel is a train: Risky behaviours in the era of social networks. Int J Soc Psychiatry. 2017 Aug;63(5):468-469.

    189) Martinotti G, Cinosi E, Santacroce R, Papanti D, Pasquini A, Mancini V, Corbo M, Fiori F, Sarchione F, Marchetti D, Verrocchio MC, Di Giannantonio M, Torrens M, Schifano F, Morlan Coarasa MJ, Merino Del Villar C. Substance-related psychopathology and aggressiveness in a nightlife holiday resort: Results from a pilot study in a psychiatric inpatient unit in Ibiza. Hum Psychopharmacol. 2017 May;32(3).

    190) Simonato P, Bersani FS, Santacroce R, Cinosi E, Schifano F, Bersani G, Martinotti G, Corazza O. Can mobile phone technology support a rapid sharing of information on novel psychoactive substances among health and other professionals internationally? Hum Psychopharmacol. 2017 May;32(3).

    191) Shafi A, Gallagher P, Stewart N, Martinotti G, Corazza O. The risk of violence associated with novel psychoactive substance misuse in patients presenting to acute mental health services. Hum Psychopharmacol. 2017 May;32(3).

    192) Santacroce R, Ruiz Bennasar C, Sancho Jaraiz JR, Fiori F, Sarchione F, Angelini F, Catalano G, Carenti ML, Corkery JM, Schifano F, Di Giannantonio M, Martinotti G. A matter of life and death: substance-caused and substance-related fatalities in Ibiza in 2015. Hum Psychopharmacol. 2017 May;32(3).

    193) Mooney R, Simonato P, Ruparelia R, Roman-Urrestarazu A, Martinotti G, Corazza O. The use of supplements and performance and image enhancing drugs in fitness settings: A exploratory cross-sectional investigation in the United Kingdom. Hum Psychopharmacol. 2017 May;32(3).

    194) Vellante F, Sarchione F, Ebisch SJH, Salone A, Orsolini L, Marini S, Valchera A, Fornaro M, Carano A, Iasevoli F, Martinotti G, Di Giannantonio M, De Berardis D. Creativity and psychiatric illness: A functional perspective beyond chaos. Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jul 5. pii: S0278-5846(17)30081-7

    195) Ebisch SJH, Gallese V, Salone A, Martinotti G, di Iorio G, Mantini D, Perrucci MG, Romani GL, Di Giannantonio M, Northoff G. Disrupted relationship between "resting state" connectivity and task-evoked activity during social perception in schizophrenia. Schizophr Res. 2017 Jul 20. pii: S0920-9964(17)30421-8

    196) Martinotti G, Montemitro C, Baroni G, Andreoli S, Alimonti F, Di Nicola M, Tonioni F, Leggio L, di Giannantonio M, Janiri L. Relationship between craving and plasma leptin concentrations in patients with cocaine addiction. Psychoneuroendocrinology. 2017 Nov;85:35-41.

    197) Lupi M, Martinotti G, Di Giannantonio M. Drunkorexia: an emerging trend in young adults. Eat Weight Disord. 2017 Dec;22(4):619-622.

    198) De Berardis D, Fornaro M, Orsolini L, Valchera A, Carano A, Vellante F, Perna, G, Serafini G, Gonda X, Pompili M, Martinotti G, Di Giannantonio M. Alexithymia and Suicide Risk in Psychiatric Disorders: A Mini-Review. Front Psychiatry. 2017 Aug 14;8:148.

    199) Meid AD, Bighelli I, Mächler S, Mikus G, Carrà G, Castellazzi M, Lucii C, Martinotti G, Nosè M, Ostuzzi G, Barbui C, Haefeli WE. Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive nature. Ther Adv Psychopharmacol. 2017 Dec;7(12):251-264.

    200) Di Nicola M, Ferri VR, Moccia L, Panaccione I, Strangio AM, Tedeschi D, Grandinetti P, Callea A, De-Giorgio F, Martinotti G, Janiri L. Gender Differences and Psychopathological Features Associated With Addictive Behaviors in Adolescents. Front Psychiatry. 2017 Dec 1;8:256.

    201) Di Cosmo G, Costantini M, Salone A, Martinotti G, Di Iorio G, Di Giannantonio M, Ferri F. Peripersonal space boundary in schizotypy and schizophrenia. Schizophr Res. 2017 Dec 18. pii: S0920-9964(17)30755-7.

    202) Lupi M, Sepede G, Cinosi E, Martinotti G, di Giannantonio M. The Efficacy of Transcranical Direct Current Stimulation in Pregabalin Abuse: A Case Report. J ECT. 2018 Jan 11.

    203) Orsolini L, Sarchione F, Vellante F, Fornaro M, Matarazzo I, Martinotti G, Valchera A, Di Nicola M, Carano A, Di Giannantonio M, Perna G, Olivieri L, De Berardis D. Protein-C reactive as biomarker predictor of schizophrenia phases of illness? A systematic review. Curr Neuropharmacol. 2018 Jan 19.

    204) Catalani V, Prilutskaya M, Al-Imam A, Marrinan S, Elgharably Y, Zloh M, Martinotti G, Chilcott R, Corazza O. Octodrine: New Questions and Challenges in Sport Supplements. Brain Sci. 2018 Feb 20;8(2).

    205) De Berardis D, Martinotti G, Di Giannantonio M. Understanding the Complex Phenomenon of Suicide: From Research to Clinical Practice. Front Psychiatry. 2018 Mar 1;9:61.

    206) Martinotti G, Santacroce R, Pettorruso M, Montemitro C, Spano MC, Lorusso M, di Giannantonio M, Lerner AG. Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives. Brain Sci. 2018 Mar 16;8(3).

    207) Bonanni L, Franciotti R, Martinotti G, Vellante F, Flacco ME, Di Giannantonio M, Thomas A, Onofrj M. Post Traumatic Stress Disorder Heralding the Onset of Semantic Frontotemporal Dementia. J Alzheimers Dis. 2018;63(1):203-215.

    208) Ioime L, Guglielmo R, Affini GF, Quatrale M, Martinotti G, Callea A, Savi E, Janiri L. Neuropsychological Performance in Alcohol Dependent Patients: A One-Year Longitudinal Study. Psychiatry Investig. 2018 Apr 20. doi: 10.30773/pi.2017.09.27.1.

    209) Metastasio A, Negri A, Martinotti G, Corazza O. Transitioning Bodies. The Case of Self-Prescribing Sexual Hormones in Gender Affirmation in Individuals Attending Psychiatric Services. Brain Sci. 2018 May 14;8(5).

    210) De Berardis D, Rapini G, Olivieri L, Di Nicola D, Tomasetti C, Valchera A, Fornaro M, Di Fabio F, Perna G, Di Nicola M, Serafini G, Carano A, Pompili M, Vellante F, Orsolini L, Martinotti G, Di Giannantonio M. Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine. Ther Adv Drug Saf. 2018 May;9(5):237-256.

    211) Pettorruso M, Spagnolo PA, Leggio L, Janiri L, Di Giannantonio M, Gallimberti L, Bonci A, Martinotti G. Repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex may improve symptoms of anhedonia in individuals with cocaine use disorder: A pilot study. Brain Stimul. 2018 Jun 5.

    212) Ostuzzi G, Mazzi MA, Terlizzi S, Bertolini F, Aguglia A, Bartoli F, Bortolaso P, Callegari C, Caroleo M, Carrà G, Corbo M, D'Agostino A, Gastaldon C, Lucii C, Magliocco F, Martinotti G, Nosé M, Ostinelli EG, Papola D, Piccinelli MP, Piccoli A, Purgato M, Tabacchi T, Turrini G, Ruggeri M, Barbui C; STAR Network. Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy. PLoS One. 2018 Aug 2;13(8):e0201371.

    213) Pettorruso M, Martinotti G, Cocciolillo F, De Risio L, Cinquino A, Di Nicola M, Camardese G, Migliara G, Moccia L, Conte E, Janiri L, Di Giuda D. Striatal presynaptic dopaminergic dysfunction in gambling disorder: A (123) I-FP-CIT SPECT study. Addict Biol. 2018 Sep 18.

    214) De Berardis D, Fornaro M, Valchera A, Cavuto M, Perna G, Di Nicola M, Serafini G, Carano A, Pompili M, Vellante F, Orsolini L, Fiengo A, Ventriglio A, Yong-Ku K, Martinotti G, Di Giannantonio M, Tomasetti C. Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors. Int J Mol Sci. 2018 Sep 23;19(10).

    215) Martinotti G, Chillemi E, Lupi M, Risio L, Pettorruso M, Giannantonio MD. Gambling disorder and bilateral transcranial direct current stimulation: A case report. J Behav Addict. 2018 Sep 1;7(3):834-837.

    216) Santacroce R, Martinotti G, di Giannantonio M. Shedding light on the "Blackout": risky behaviors and accidental deaths among adolescents. Acta Psychiatr Scand. 2019 Jan;139(1):98-99.

    217) Clerici M, de Bartolomeis A, De Filippis S, Ducci G, Maremmani I, Martinotti G, Schifano F. Patterns of Management of Patients With Dual Disorder (Psychosis) in Italy: A Survey of Psychiatrists and Other Physicians Focusing on Clinical Practice. Front Psychiatry. 2018 Nov 13;9:575.

    218) Fineberg NA, Demetrovics Z, Stein DJ, Ioannidis K, Potenza MN, Grünblatt E, Brand M, Billieux J, Carmi L, King DL, Grant JE, Yücel M, Dell'Osso B, Rumpf HJ, Hall N, Hollander E, Goudriaan A, Menchon J, Zohar J, Burkauskas J, Martinotti G, Van Ameringen M, Corazza O, Pallanti S; COST Action Network, Chamberlain SR. Manifesto for a European research network into Problematic Usage of the Internet. Eur Neuropsychopharmacol. 2018 Nov;28(11):1232-1246.

    219) Moccia L, Tofani A, Mazza M, Covino M, Martinotti G, Schifano F, Janiri L, Di Nicola M. Dorsolateral Prefrontal Cortex Impairment in Methoxetamine-Induced Psychosis: An (18)F-FDG PET/CT Case Study. J Psychoactive Drugs. 2019 Feb 9:1-6.

    220) Pettorruso M, Di Giuda D, Martinotti G, Cocciolillo F, De Risio L, Montemitro C, Camardese G, Di Nicola M, Janiri L, di Giannantonio M; NST Study Group. Dopaminergic and clinical correlates of high-frequency repetitive transcranial magnetic stimulation in gambling addiction: a SPECT case study. Addict Behav. 2019 Feb 14;93:246-249.


    Corsi di Laurea Master e Post Laurea

    Ateneo partner o membro di